Vulnerable Plaque Diagnosis, Treatment: Is Enrollment “Impossible”?
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic modalities and therapies for vulnerable plaque should be tested simultaneously in one clinical trial to ensure the enrollment size is manageable, according to cardiac researcher James Muller, MD, Massachusetts General Hospital